InsidersTradesSigma
Explore the complete record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Officer active across 1 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 1 reports have been published. Total volume traded: €10.9m. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration